NFKB1 and Parkinson disease: Liu et al. demonstrated that butyrate supplementation exerts neuroprotective effects, by inhibiting neuroinflammation and dopaminergic cell death, through the suppression of microglial activation by modulating the RAS-NFkB signaling pathway in a parkinsonism induction model with MPTP [33].